You are here
- Home
- Total number of clinical trials
Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression
- Disease
- bipolar disorder
- Drug Name
- Seroquel XR
- Generic Name
- Quetiapine
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- III
- Start Date
- Dec 16, 2010
- Study Name
- D144CC00005
- Study Id
- D144CC00005
- ClinicalTrials.gov ID
- NCT01256177
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
